Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (331-340 of 528) with videos related to

Pageof 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)Katherine L Nathanson, Anne-Marie Martin, Bradley Wubbenhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic targetGuo Chen, Nitin Chakravarti, Kimberly Aardalen, et al.
Human Molecular Genetics|May 10, 2011
A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibilityPeter A Kanetsky, Nandita Mitra, Saran Vardhanabhuti, et al.
Cancer Research|February 15, 2011
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expressionKim H T Paraiso, Yun Xiang, Vito W Rebecca, et al.
Cancer Research|February 20, 2007
Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysisMarcelo A Carvalho, Sylvia M Marsillac, Rachel Karchin, et al.
Nature Communications|November 7, 2022
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, et al.
Cancer Cell|September 10, 2014
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancerXiaowen Hu, Yi Feng, Dongmei Zhang, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Cancer Research|June 25, 2009
Active Notch1 confers a transformed phenotype to primary human melanocytesChelsea C Pinnix, John T Lee, Zhao-Jun Liu, et al.
Pageof 53

Showing results (331-340 of 528) with videos related to

Sort By:
Pageof 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)Katherine L Nathanson, Anne-Marie Martin, Bradley Wubbenhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic targetGuo Chen, Nitin Chakravarti, Kimberly Aardalen, et al.
Human Molecular Genetics|May 10, 2011
A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibilityPeter A Kanetsky, Nandita Mitra, Saran Vardhanabhuti, et al.
Cancer Research|February 15, 2011
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expressionKim H T Paraiso, Yun Xiang, Vito W Rebecca, et al.
Cancer Research|February 20, 2007
Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysisMarcelo A Carvalho, Sylvia M Marsillac, Rachel Karchin, et al.
Nature Communications|November 7, 2022
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, et al.
Cancer Cell|September 10, 2014
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancerXiaowen Hu, Yi Feng, Dongmei Zhang, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Cancer Research|June 25, 2009
Active Notch1 confers a transformed phenotype to primary human melanocytesChelsea C Pinnix, John T Lee, Zhao-Jun Liu, et al.
Pageof 53